Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIC for Stem Cell Transplantation in Severe Immunodeficiency
NCT00613561Phase 2Unknown
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Dec 2007
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan, antithymocyte globulin rabbit in primary immunodeficiency (PI), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Status: unknown.
02
Drugs
fludarabinebusulfanantithymocyte globulin rabbit
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT00613561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00613561.